Novel loss-of-function mutation in <i>HERC2</i> is associated with severe developmental delay and paediatric lethality.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32571899.
- Also identified by DOI 10.1136/jmedgenet-2020-106873 and PMC identifier 8086253.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The <i>HERC2</i> gene encodes a 527 kDa E3 ubiquitin protein ligase that has key roles in cell cycle regulation, spindle formation during mitosis, mitochondrial functions and DNA damage responses. It has essential roles during embryonic development, particularly for neuronal and muscular functions. To date, missense mutations in <i>HERC2</i> have been associated with an autosomal recessive neurodevelopmental disorder with some phenotypical similarities to Angelman syndrome, and a homozygous deletion spanning <i>HERC2</i> and <i>OCA2</i> causing a more severe neurodevelopmental phenotype. We ascertained a consanguineous family with a presumed autosomal recessive severe neurodevelopmental disorder that leads to paediatric lethality. In affected individuals, we identified a homozygous <i>HERC2</i> frameshift variant that results in a premature stop codon and complete loss of HERC2 protein. Functional characterisation of this variant in fibroblasts, from one living affected individual, revealed impaired mitochondrial network and function as well as disrupted levels of known interacting proteins such as XPA. This study extends the genotype-phenotype correlation for <i>HERC2</i> variants to include a distinct lethal neurodevelopmental disorder, highlighting the importance of further characterisation for <i>HERC2</i>-related disorders.
Medical subject headings
- Genes, Lethal
- Loss of Function Mutation
- Neurodevelopmental Disorders
- Ubiquitin-Protein Ligases